Is It Possible to Prevent Ovarian Hyperstimulation Syndrome by Gonadotropin-Releasing Hormone Agonist Triggering and Modified Luteal Support in Patients With Polycystic Ovarian Morphology?

BACKGROUND: Gonadotropin-releasing hormone (GnRH) agonist triggering plus 1,500 IU human chorionic gonadotropin (hCG) supplementation protocol was previously claimed effective in reducing the ovarian hyperstimulation syndrome (OHSS) incidence in high responders. METHODS: This retrospective study inc...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Clin Med Res
Auteurs principaux: Gurbuz, Ali Sami, Deveer, Ruya, Kucuk, Mert, Ozcimen, Necati, Incesu, Dilek, Koseoglu, Sezen
Format: Artigo
Langue:Inglês
Publié: Elmer Press 2016
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4817580/
https://ncbi.nlm.nih.gov/pubmed/27081426
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr2500w
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires